BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply

Emmanuel B. Walter; Kawsar R. Talaat; Alejandra Gurtman

doi:10.1056/NEJMc2118775

BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply

Emmanuel B. Walter, Kawsar R. Talaat, Alejandra Gurtman

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	606
Number of pages	1
Journal	The New England journal of medicine
Volume	386
Issue number	6
DOIs	https://doi.org/10.1056/NEJMc2118775
State	Published - Feb 10 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc2118775

Cite this

@article{8e867fd8139446c9b05b290d242113ba,

title = "BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply",

author = "Walter, {Emmanuel B.} and Talaat, {Kawsar R.} and Alejandra Gurtman",

year = "2022",

month = feb,

day = "10",

doi = "10.1056/NEJMc2118775",

language = "English (US)",

volume = "386",

pages = "606",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "6",

}

TY - JOUR

T1 - BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply

AU - Walter, Emmanuel B.

AU - Talaat, Kawsar R.

AU - Gurtman, Alejandra

PY - 2022/2/10

Y1 - 2022/2/10

UR - http://www.scopus.com/inward/record.url?scp=85124444553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124444553&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2118775

DO - 10.1056/NEJMc2118775

M3 - Letter

C2 - 35045225

AN - SCOPUS:85124444553

SN - 0028-4793

VL - 386

SP - 606

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 6

ER -

BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this